These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3489314)

  • 41. Characterization of viral polyproteins in cells transformed and producing Moloney murine sarcoma virus-124.
    Wood TG; Lyons DD; Ng VL; Murphy EC; Arlinghaus RB
    Biochim Biophys Acta; 1980 Jul; 608(2):215-31. PubMed ID: 6156703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors.
    Li KJ; Garoff H
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11658-63. PubMed ID: 8876192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Translational order of bovine leukemia virus gag and env gene-coded proteins.
    Uckert W; Grófová M; Beaudreau G
    Virology; 1984 May; 135(1):288-92. PubMed ID: 6328752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of inhibitors of lipid synthesis on the replication of Rous sarcoma virus. A specific effect of cerulenin on the processing of major non-glycosylated viral structural proteins.
    Goldfine H; Harley JB; Wyke JA
    Biochim Biophys Acta; 1978 Sep; 512(2):229-40. PubMed ID: 213112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses.
    Gorska-Flipot I; Huang M; Cantin M; Rassart E; Massé G; Jolicoeur P
    J Virol; 1992 Dec; 66(12):7201-10. PubMed ID: 1433513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins.
    Yoshinaka Y; Katoh I; Copeland TD; Smythers GW; Oroszlan S
    J Virol; 1986 Mar; 57(3):826-32. PubMed ID: 3005629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure of the murine leukemia virus envelope glycoprotein precursor.
    Witte ON; Wirth DF
    J Virol; 1979 Feb; 29(2):735-43. PubMed ID: 430608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyprotein precursors to mouse mammary tumor virus proteins.
    Anderson SJ; Naso RB; Davis J; Bowen JM
    J Virol; 1979 Nov; 32(2):507-16. PubMed ID: 228073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and characterization of a mouse cell line containing a defective Moloney murine leukemia virus genome.
    Besmer P; Fan H; Paskind M; Baltimore D
    J Virol; 1979 Mar; 29(3):1023-34. PubMed ID: 221665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release.
    Low A; Datta S; Kuznetsov Y; Jahid S; Kothari N; McPherson A; Fan H
    J Virol; 2007 Apr; 81(8):3685-92. PubMed ID: 17267509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of Friend mink cell focus-inducing murine leukemia virus envelope proteins.
    Pinter A; Honnen WJ; Li JS
    Virology; 1984 Jul; 136(1):196-210. PubMed ID: 6330991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytoskeleton-associated Pr65gag and retrovirus assembly.
    Edbauer CA; Naso RB
    Virology; 1983 Oct; 130(2):415-26. PubMed ID: 6196908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
    Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
    J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigenic differences among multiply charged Moloney murine leukemia virus p30 polypeptides found inside infected cells.
    Ikuta K; Luftig RB
    Virus Res; 1986 Nov; 6(2):101-8. PubMed ID: 2432739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerulenin blocks fatty acid acylation of glycoproteins and inhibits vesicular stomatitis and Sindbis virus particle formation.
    Schlesinger MJ; Malfer C
    J Biol Chem; 1982 Sep; 257(17):9887-90. PubMed ID: 6286658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural interactions between retroviral Gag proteins examined by cysteine cross-linking.
    Hansen MS; Barklis E
    J Virol; 1995 Feb; 69(2):1150-9. PubMed ID: 7815493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses.
    Conti G; Portincasa P; Chezzi C
    Res Virol; 1995; 146(2):141-9. PubMed ID: 7638438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of phosphorylated forms of Moloney murine leukemia virus major capsid protein p30 by immunoprecipitation and two-dimensional gel electrophoresis.
    Ikuta K; Luftig RB
    J Virol; 1988 Jan; 62(1):40-6. PubMed ID: 3334749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity.
    Yoshinaka Y; Luftig RB
    Virology; 1982 Apr; 118(2):380-8. PubMed ID: 6178211
    [No Abstract]   [Full Text] [Related]  

  • 60. Characterization of intracellular precursor polyproteins of Moloney murine leukemia virus.
    Ng VL; Wood TG; Lyons DD; Arlinghaus RB
    J Virol; 1979 Dec; 32(3):1051-6. PubMed ID: 92574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.